Close X
Attorney Spotlight

How does Jessie Zeigler anticipate the intersection of privacy and smart technology will impact the future of litigation? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Primary Care Providers Win Challenge of CMS Interpretation of Enhanced Payment Law

With the help and support of the Tennessee Medical Association, 21 Tennessee physicians of underserved communities joined together and retained Bass, Berry & Sims to file suit against the Centers for Medicare & Medicaid Services to stop improper collection efforts. Our team, led by David King, was successful in halting efforts to recoup TennCare payments that were used legitimately to expand services in communities that needed them. Read more

Tennessee Medical Association & Bass, Berry & Sims

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Healthcare Private Equity Compliance Checklist

The complex and ever-changing healthcare regulatory and enforcement environment, including increased focus on the role of private equity firms in their portfolio companies, make compliance a top priority for private equity firms investing in healthcare companies. The best way to limit your exposure as a private equity firm is to avoid a compliance misstep in the first place. Additionally, an effective and robust compliance program for your portfolio healthcare company makes it much more attractive to potential buyers and helps you avoid an unexpected and costly investigation or valuation hit down the road. Download the Healthcare Private Equity Compliance Checklist to assess whether your portfolio company's compliance program is up-to-date.

Click here to download the checklist.

Abby Yi

Associate

Abby Yi

Associate

Washington, D.C.
(202) 827-2997 TEL
(202) 747-7639 FAX
Washington, D.C.
(202) 827-2997 TEL
(202) 747-7639 FAX

Abby Yi represents companies in connection with internal and government investigations concerning white collar and corporate compliance matters. In addition, Abby regularly works with healthcare companies on healthcare fraud and abuse issues related to alleged violations under the False Claims Act, Anti-Kickback Statute and Stark Law.

Prior to joining Bass, Berry & Sims, Abby worked as an Investigator in the Office of Fraud Detection and Market Intelligence at the Financial Industry Regulatory Authority (FINRA). In this capacity, she conducted investigations of potential federal securities laws and FINRA rule violations. She previously worked as a legal intern at the Department of Justice, U.S. Securities and Exchange Commission, and the New York State Attorney General's Office. Abby also served as a judicial intern for The Honorable Judge John Mott in the Superior Court of the District of Columbia.

Memberships

Asian Pacific American Bar Association of the Greater Washington, D.C. Area (APABA-DC)

Korean American Bar Association for the Washington, D.C. Area (KABA-DC)

International Association of Korean Lawyers – DC Conference Host Committee Member (2016)

News

View More

Representative Experience

View More

Publications

View More

Accolades

FINRA Office of Fraud Detection and Market Intelligence – Winner, 2016 Case of the Year Award

American University Washington College of Law – Exceptional Pro Bono Public Service Award

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.